pidotimod has been researched along with Toxoplasmosis, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, YH; Chen, H; Chen, ZW; Du, J; Fu, Y; Huo, XX; Lu, FL; Lun, ZR; Luo, QL; Shen, JL; Song, XR; Wang, H; Wang, L; Wang, Y; Xu, XC; Xu, YH; Zhang, AM | 1 |
| Chen, H; Huo, XX; Kong, LT; Li, M; Shen, JL; Wang, WW; Zhang, Q | 1 |
2 other study(ies) available for pidotimod and Toxoplasmosis, Animal
| Article | Year |
|---|---|
Preventive effect of pidotimod on reactivated toxoplasmosis in mice.
Topics: Animals; Cyclophosphamide; Cytokines; Female; Gene Expression Regulation; Immunologic Factors; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Parasitemia; Pyrrolidonecarboxylic Acid; Specific Pathogen-Free Organisms; Spleen; Thiazolidines; Toxoplasmosis, Animal | 2013 |
[Pidotimod inhibits activation of latent Toxoplasma gondii infection induced by dexamethasone in mice].
Topics: Animals; Brain; Cytokines; Dexamethasone; DNA, Protozoan; Female; Mice; Mice, Inbred BALB C; Pyrrolidonecarboxylic Acid; T-Lymphocytes, Regulatory; Th1 Cells; Th2 Cells; Thiazolidines; Toxoplasma; Toxoplasmosis, Animal | 2013 |